All Stories

  1. Dermatophytosis in Iran: a sharp increase in cases caused by Trichophyton mentagrophytes var. indotineae
  2. Antifungal Efficacy of Luliconazole-Loaded Nanostructured Lipid-Carrier Gel in an Animal Model of Dermatophytosis
  3. Characterization of COVID‐19‐Associated Candidemia Among Burn Patients
  4. A Novel Niosomal Gel for Topical Delivery of Miltefosine Against Trichophyton indotineae Dermatophytosis in Animal Model
  5. Molecular epidemiology of dermatophytosis in Golestan, Iran: A cross-sectional study
  6. High Prevalence of Azole‐Resistant Aspergillus fumigatus Among Iranian Cystic Fibrosis Patients: Should We Be Concerned?
  7. Multi‐state evaluation of Candida infections in burn patients
  8. Metabolic Patterns of Fluconazole Resistant and Susceptible Candida auris Clade V and I
  9. Synthesis, computational study, and antileishmanial and antifungal evaluation of phenoxyacetophenone hydrazones bearing a 4-arylthiazole moiety
  10. Molecular typing of a collection of Iranian clinical Trichophyton tonsurans isolates based on the non‐transcribed spacer region of rDNA and antifungal susceptibility testing of the species
  11. Potential Inhibitory Effect of Miltefosine against Terbinafine-Resistant Trichophyton indotineae
  12. Caspian Sea Mycosands: The Variety and Abundance of Medically Important Fungi in Beach Sand and Water
  13. Confirmation of fifth Candida auris clade by whole genome sequencing
  14. A Whole Genome Sequencing-Based Approach to Track down Genomic Variants in Itraconazole-Resistant Species of Aspergillus from Iran
  15. Five Years Surveillance Study of Clinical and Environmental Triazole‐Resistant Aspergillus fumigatus Isolates in Iran
  16. Otomycosis: The foremost aetiological agent causing otitis externa and the antifungal susceptibility pattern in North‐Western Iran
  17. Comparative analysis of galactomannan lateral flow assay, galactomannan enzyme immunoassay and BAL culture for diagnosis of COVID‐19‐associated pulmonary aspergillosis
  18. Development of RFLP method for rapid differentiation of Aspergillus flavus and Aspergillus oryzae, two species with high importance in clinical and food microbiology
  19. In vitro activity of 23 antifungal drugs against 54 clinical and environmental Aspergillus oryzae isolates
  20. Eumycetoma causative agents are inhibited in vitro by luliconazole, lanoconazole and ravuconazole
  21. Differentiation of Aspergillus flavus from Aspergillus oryzae Targeting the cyp51A Gene
  22. In vitro antifungal activity of Thymus vulgaris essential oil nanoemulsion
  23. Diversity of Geophilic Dermatophytes Species in the Soils of Iran; The Significant Preponderance of Nannizzia fulva
  24. In vitro activities of antifungal drugs against a large collection of Trichophyton tonsurans isolated from wrestlers
  25. Galactomannan detection in bronchoalveolar lavage fluids: A diagnostic approach for fungus ball in patients with pulmonary tuberculosis?
  26. Prevalence of allergic bronchopulmonary aspergillosis in cystic fibrosis patients using two different diagnostic criteria
  27. Relationship between spirometry results and colonisation of Aspergillus species in allergic asthma
  28. Molecular epidemiology of Tinea gladiatorum in contact sports in northern Iran
  29. <p>Emergence of Terbinafine Resistant <em>Trichophyton mentagrophytes</em> in Iran, Harboring Mutations in the Squalene Epoxidase (<em>SQLE</em>) Gene</p>
  30. Antifungal Activity of a Novel Triazole, Efinaconazole and Nine Comparators against 354 Molecularly Identified Aspergillus Isolates
  31. Indole-derived chalcones as anti-dermatophyte agents: In vitro evaluation and in silico study
  32. Species distribution and susceptibility profiles of Candida species isolated from vulvovaginal candidiasis, emergence of C. lusitaniae
  33. Molecular epidemiology and antifungal susceptibility profiles of clinical Cryptococcus neoformans/Cryptococcus gattii species complex
  34. Genetic diversity and antifungal susceptibility patterns of Aspergillus nidulans complex obtained from clinical and environmental sources
  35. A multi-centered study of Pneumocystis jirovecii colonization in patients with respiratory disorders: Is there a colonization trend in the elderly?
  36. In vitro activities of 15 antifungal drugs against a large collection of clinical isolates of Microsporum canis
  37. Discrimination of Aspergillus flavus from Aspergillus oryzae by matrix‐assisted laser desorption/ionization time‐of‐flight (MALDI‐TOF) mass‐spectrometry
  38. Trichophyton mentagrophytes and T interdigitale genotypes are associated with particular geographic areas and clinical manifestations
  39. Potential Fifth Clade ofCandida auris,Iran, 2018
  40. Identification of clinical dermatophyte isolates obtained from Iran by matrix-assisted laser desorption/ionization time-offlight mass spectrometry
  41. Novel Point Mutations in cyp51A and cyp51B Genes Associated with Itraconazole and Posaconazole Resistance in Aspergillus clavatus Isolates
  42. Fungal epidemiology in cystic fibrosis patients with a special focus on Scedosporium species complex
  43. Candida auris otomycosis in Iran and review of recent literature
  44. Niosome-loaded antifungal drugs as an effective nanocarrier system: A mini review
  45. Prevalence of specific immunoglobulin E and G against Aspergillus fumigatus in patients with asthma
  46. Prosthetic valve endocarditis caused by multidrug-resistant Candida albicans in a patient with myelodysplasia syndrome: A case report and literature review
  47. Low In Vitro Antifungal Activity of Tavaborole against Yeasts and Molds from Onychomycosis
  48. In-vitro antifungal susceptibility testing of lanoconazole and luliconazole against Aspergillus flavus as an important agent of invasive aspergillosis
  49. Molecular identification and antifungal susceptibility testing of Candida species isolated from dental plaques
  50. Promising antileishmanial activity of novel imidazole antifungal drug luliconazole against Leishmania major: In vitro and in silico studies
  51. Potent Activities of Luliconazole, Lanoconazole, and Eight Comparators against Molecularly Characterized Fusarium Species
  52. In Vitro Antifungal Activity of Novel Triazole Efinaconazole and Five Comparators against Dermatophyte Isolates
  53. Identification of uncommon oral yeasts from cancer patients by MALDI-TOF mass spectrometry
  54. Use of cell surface protein typing for genotyping of azole-resistant and -susceptible Aspergillus fumigatus isolates in Iran
  55. Invasive forms of Candida and Aspergillus in sputum samples of pulmonary tuberculosis patients attending the tuberculosis reference laboratory in Ghaemshahr, Northern Iran: An analysis of samples collected during the past 10years
  56. Characterization of clinically important dermatophytes in North of Iran using PCR-RFLP on ITS region
  57. Discrimination of Aspergillosis, Mucormycosis, Fusariosis, and Scedosporiosis in Formalin-Fixed Paraffin-Embedded Tissue Specimens by Use of Multiple Real-Time Quantitative PCR Assays
  58. Potent Activities of Novel Imidazoles Lanoconazole and Luliconazole against a Collection of Azole-Resistant and -Susceptible Aspergillus fumigatus Strains
  59. In vitroactivity of new azoles luliconazole and lanoconazole compared with ten other antifungal drugs against clinical dermatophyte isolates: Table 1.
  60. Staphylococcus aureus Enterotoxin B Down-Regulates the Expression of Transforming Growth Factor-Beta (TGF-β) Signaling Transducers in Human Glioblastoma
  61. Genetic and Morphological Diversity of the Genus Penicillium From Mazandaran and Tehran Provinces, Iran
  62. The First Case of Total Dystrophic Onychomycosis Caused by Aspergillus clavatus Resistant to Antifungal Drugs
  63. PCR-RFLP on β-tubulin gene for rapid identification of the most clinically important species of Aspergillus
  64. Dermatophytosis due to Microsporum incurvatum: Notification and Identification of a Neglected Pathogenic Species
  65. History of treated pulmonary tuberculosis will also be an underlying symptom of opportunistic aspergillosis by Aspergillus flavus: A case report
  66. Coexistence of opportunistic mycosis and mycobacterium tuberculosis in patients attending the Central Tuberculosis Reference Laboratory of Ghaemshahr city, Iran
  67. Restriction Analysis of β-Tubulin Gene for Differentiation of the Common Pathogenic Dermatophytes
  68. Evaluation of antitumor activity of a TGF-beta receptor I inhibitor (SD-208) on human colon adenocarcinoma
  69. Microsporum fulvum, an Ignored Pathogenic Dermatophyte: A New Clinical Isolation from Iran